As of 2026-06-08, the Intrinsic Value of Utah Medical Products Inc (UTMD) is 59.99 USD. This UTMD valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 67.65 USD, the upside of Utah Medical Products Inc is -11.30%.
The range of the Intrinsic Value is 55.19 - 67.11 USD
Based on its market price of 67.65 USD and our intrinsic valuation, Utah Medical Products Inc (UTMD) is overvalued by 11.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 55.19 - 67.11 | 59.99 | -11.3% |
| DCF (Growth 10y) | 57.89 - 69.99 | 62.79 | -7.2% |
| DCF (EBITDA 5y) | 61.24 - 72.89 | 68.25 | 0.9% |
| DCF (EBITDA 10y) | 62.94 - 75.60 | 69.95 | 3.4% |
| Fair Value | 17.06 - 17.06 | 17.06 | -74.78% |
| P/E | 84.74 - 131.48 | 105.61 | 56.1% |
| EV/EBITDA | 65.37 - 95.76 | 79.42 | 17.4% |
| EPV | 95.67 - 114.68 | 105.18 | 55.5% |
| DDM - Stable | 16.70 - 33.17 | 24.93 | -63.1% |
| DDM - Multi | 17.99 - 28.08 | 21.94 | -67.6% |
| Market Cap (mil) | 215.13 |
| Beta | 0.95 |
| Outstanding shares (mil) | 3.18 |
| Enterprise Value (mil) | 127.72 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.28% |
| Cost of Debt | 5.00% |
| WACC | 8.15% |